Statement by Fragrance Creators Congress’ Support of Funding for the Modernization of Cosmetics Regulation Act

Fragrance Creators president and CEO Farah K. Ahmed writes, 'Fragrance plays an important role in cosmetics and personal care products; products that nurture skin health and hygiene, empower self-expression and confidence, and deliver generational delight to billions of people every day.'
Fragrance Creators president and CEO Farah K. Ahmed writes, "Fragrance plays an important role in cosmetics and personal care products; products that nurture skin health and hygiene, empower self-expression and confidence, and deliver generational delight to billions of people every day."
AdobeStock

Fragrance Creators president and CEO Farah K. Ahmed shared a statement regarding Congress' support of funding for the Modernization for Cosmetics Regulation Act

“We are grateful to the Senate Appropriations Committee for approving the Fiscal Year 2024 appropriations bill that includes $7 million to the Food and Drug Administration (FDA) to support implementation of the Modernization of Cosmetics Regulation Act (MoCRA).

Fragrance plays an important role in cosmetics and personal care products; products that nurture skin health and hygiene, empower self-expression and confidence, and deliver generational delight to billions of people every day. 

Throughout the legislative process, Fragrance Creators focused on the fragrance-related provisions of MoCRA as we worked with Congressional champions and other stakeholders to help develop and enact the law.  This resulted in FDA’s new expanded authority to develop regulations that advance sound science, safety, and innovation as well as drive consumer trust and access to a diverse and inclusive array of cosmetic and personal care products.  For this, adequate funding of MoCRA implementation is critical. 

We recognize Chair Murray and Ranking Member Collins, who helped author MoCRA, and the Subcommittee Chair and Ranking Member, Senators Heinrich and Hoeven, for their effort to include this initial implementation funding in a complex budget climate.  Coupled with an expression of support by the House Appropriations Committee last week, yesterday’s funding allocation is a step in the right direction towards fueling FDA’s development of modernized, evidence-based cosmetics regulation that meets the needs of today’s and tomorrow’s consumer.”

More in Personal Care/Beauty